By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cartagenia has opened its first North American office in Boston, the Leuven, Belgium-based bioinformatics firm said today.

The opening of the new office follows recently signed contracts with GeneDx and the Los Angeles Children's Hospital.

The firm also said that it has named Drew Arnold, VP of sales and business development for North America, to head the office. He joins Cartagenia from GenomeQuest, where he headed the global sales team.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.